Where are we at with model-based economic evaluations of interventions for dementia? a systematic review and quality assessment
Open Access
- 1 November 2018
- journal article
- review article
- Published by Elsevier in International Psychogeriatrics
- Vol. 30 (11) , 1593-1605
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Cost-Effectiveness of Magnetic Resonance Imaging with a New Contrast Agent for the Early Diagnosis of Alzheimer's DiseasePLOS ONE, 2012
- Evaluating the cost effectiveness of donepezil in the treatment of Alzheimer's disease in Germany using discrete event simulationBMC Neurology, 2012
- Health economics research into supporting carers of people with dementia: A systematic review of outcome measuresHealth and Quality of Life Outcomes, 2012
- Impact of early intervention and disease modification in patients with predementia Alzheimer’s disease: a Markov model simulationClinicoEconomics and Outcomes Research, 2011
- Cost Effectiveness of Donepezil in the Treatment of Mild to Moderate Alzheimerʼs DiseasePharmacoEconomics, 2010
- Modelling Disease Progression in??Alzheimer???s DiseasePharmacoEconomics, 2007
- Health utilities in mild cognitive impairment and dementia: a population study in SwedenInternational Journal of Geriatric Psychiatry, 2006
- Good Practice Guidelines for Decision-Analytic Modelling in Health Technology AssessmentPharmacoEconomics, 2006
- Cost Effectiveness of Memantine in Alzheimer???s DiseaseDrugs & Aging, 2004
- The economic impact of tacrine in the treatment of Alzheimer's diseaseClinical Therapeutics, 1997